June 12, 2026 · Form 4 insider transaction
Karas Eric bought 25,000 shares of ARS Pharmaceuticals, Inc. at $1.50 per share, a transaction worth $37.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Includes 1,861 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2025.